SCHEMBL25746591

SCHEMBL25746591

Cc1cc2nc(C)c(O)c(C)n2n1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.46
CYP1A2 P05177 1/20 0.45
USP2 O75604 1/20 0.39
TSHR P16473 1/20 0.39
HTT P42858 1/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
ALDH1A1 P00352 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
PIK3CG P48736 2/20 0.36
POLB P06746 1/20 0.36
MAOB P27338 1/20 0.36
DPP4 P27487 1/20 0.35
TP53 P04637 1/20 0.35
MAPT P10636 1/20 0.34
AURKA O14965 1/20 0.34
CSF1R P07333 1/20 0.34
RET P07949 1/20 0.34
LTK P29376 1/20 0.34
CSNK1A1 P48729 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7801386 0.79 KDM4E (0.49) KDM4ECYP1A2USP2TSHRHTT
SCHEMBL19194883 0.76 KDM4E (0.46) KDM4ECYP1A2USP2TSHRHTT
SCHEMBL5071803 0.74 CYP1A2 (0.47) KDM4ECYP1A2USP2TSHRMEN1
SCHEMBL5199195 0.73 PIK3CG (0.44) KDM4ECYP1A2USP2TSHRHTT
SCHEMBL16739096 0.73 KDM4E (0.44) KDM4ECYP1A2USP2TSHRHTT
SCHEMBL14211728 0.72 KDM4E (0.42) KDM4ECYP1A2USP2TSHRHTT
SCHEMBL14211736 0.72 PIK3CG (0.47) KDM4EUSP2TSHRHTTALDH1A1
SCHEMBL12797755 0.71 CYP1A2 (0.43) KDM4ECYP1A2USP2TSHRHTT
SCHEMBL2270920 0.71 KDM4E (0.43) KDM4ECYP1A2HTTALDH1A1PIK3CG
SCHEMBL12838060 0.71 KDM4E (0.41) KDM4ECYP1A2USP2TSHRMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230192704-A1 MONOCARBOXYLIC ACID TRANSPORTER 4 (MCT4) MODULATORS AND USES THEREOF TEON THERAPEUTICS INC (US) 2023-06-22 US disclosed
US-20230192704-A1 MONOCARBOXYLIC ACID TRANSPORTER 4 (MCT4) MODULATORS AND USES THEREOF TEON THERAPEUTICS INC (US) 2023-06-22 US disclosed
US-20230192704-A1 MONOCARBOXYLIC ACID TRANSPORTER 4 (MCT4) MODULATORS AND USES THEREOF TEON THERAPEUTICS INC (US) 2023-06-22 US disclosed
EP-4153652-A1 MONOCARBOXYLIC ACID TRANSPORTER 4 (MCT4) MODULATORS AND USES THEREOF Teon Therapeutics, Inc. (US) 2023-03-29 EP disclosed
WO-2021236893-A1 MONOCARBOXYLIC ACID TRANSPORTER 4 (MCT4) MODULATORS AND USES THEREOF TEON THERAPEUTICS, INC. (US) 2021-11-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230192704-A1 MONOCARBOXYLIC ACID TRANSPORTER 4 (MCT4) MODULATORS AND USES THEREOF SLC16A3, SLC16A1, SLC16A8 KDM4E 2651/4885CYP1A2 4633/4885USP2 3327/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.